JamesRkaye

Vix spread Betting/CFD strategy. Highest profit factor ever?

JamesRkaye Telah dikemas kini   
Recently I have noticed that many CFD and spread betting providers (I wont mention which ones but they are easy to find with a quick google search) are letting users "trade" the CBOE Volatility Index ( VIX ). I thought this was unusual as the VIX is not a purchasable asset; it is a measure of implied volatility (both long and short) on the S&P500 calculated through a formula using the price of S&P options. As far as I know the VIX has never been directly tradeable until now, VIX related products like ETFs which attempt to follow the VIX has been available for nearly two decades however they suffer greatly from slippage which makes them difficult to trade.
I am astonished that we are now, for the first time, able to bet on the result of a formula. I think that CFD and spread betting providers have made a mistake, they were probably just looking to add more tradable products and didn't think through fully that the VIX is not like any of their other products, and is much easier to profit from when using a quantitative strategy.
This strategy works live on 4H and daily charts and achieves absolutely ridiculous results. I set it to start with $100 initial capital, and over the course of 465 trades it made $73154339495899.86 profit due to compounding profits. This is a profit factor of 695603.753. I don't expect to earn this much profit myself as I am sure that CFD and spread betting providers will eventually realize that it was a mistake to let traders have positions betting on the outcome of a formula, and eventually stop allowing VIX trades to be placed. I am currently trading using this algorithm, and will maybe let others use this script eventually after I've had my fun. So follow me :)
Nota Keluaran:
Tradingview seemed to change something on pinescript which retroactively broke the last version.
Skrip jemputan sahaja

Akses ke skrip ini adalah terhad kepada pengguna yang diberikan akses oleh penulis dan kebiasaannya memerlukan pembayaran. Anda boleh menambahkannya kepada senarai kegemaran anda, tetapi anda hanya dapat menggunakannya setelah meminta izin dan mendapatkannya dari penulis. Sila hubungi JamesRkaye untuk lebih maklumat atau rujuk arahan penulis seperti di bawah.

TradingView tidak mencadangkan untuk membayar untuk sesuatu skrip dan menggunakannya sehingga anda adalah 100% mempercayai penulisnya dan memahami bagaimana skrip itu berfungsi. Dalam banyak kes, anda boleh mencari alternatif sumber terbuka yang bagus secara percuma di Skrip Komunitikami.

Penafian

Maklumat dan penerbitan adalah tidak dimaksudkan untuk menjadi, dan tidak membentuk, nasihat untuk kewangan, pelaburan, perdagangan dan jenis-jenis lain atau cadangan yang dibekalkan atau disahkan oleh TradingView. Baca dengan lebih lanjut di Terma Penggunaan.

Ingin menggunakan skrip ini pada carta?

Amaran: sila baca sebelum memohon akses.